References in Evolving novel anti-HER2 strategies - The Lancet Oncology
Herceptin® (trastuzumab) for HER2+ Cancer
Trastuzumab: triumphs and tribulations | Oncogene
Pertuzumab and Its Accelerated Approval: Evolving Treatment Paradigms and New Challenges in the Management of HER2-Positive Breast Cancer
References in Evolving novel anti-HER2 strategies - The Lancet Oncology
Cancers | Free Full-Text | Mechanisms Underlying the Action and Synergism of Trastuzumab and Pertuzumab in Targeting HER2-Positive Breast Cancer | HTML
IJMS | Free Full-Text | Molecular Mechanisms and Translational Therapies for Human Epidermal Receptor 2 Positive Breast Cancer | HTML
Trastuzumab in the Treatment of Breast Cancer | SpringerLink
Structure of trastuzumab emtansine and mechanisms of action. Notes: On... | Download Scientific Diagram
Breast cancer drug trastuzumab induces cardiac toxicity: evaluation of human epidermal growth factor receptor 2 as a potential diagnostic and prognostic marker
Figure 2: Mechanism of Action of Trastuzumab and Pathogenesis of its Cardiotoxicity | Radcliffe Cardiology
Trastuzumab emtansine: mechanisms of action and drug resistance | Breast Cancer Research | Full Text
Resistant mechanism to trastuzumab. (1) Steric effects or masking of... | Download Scientific Diagram
Novel treatment strategies for patients with HER2‑positive breast cancer who do not benefit from current targeted therapy drugs (Review)
Trastuzumab (Herceptin) | American Journal of Neuroradiology